Acute Coronary Syndrome. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction
Conditions
Interventions
Intervention 1: Intervention group: 100% myrtle essential oil, one drop, 2 times for 3 days, 10 minutes each time, inhalation with oxygen mask, Bayhaqi Pharmaceutical Company. Intervention 2: Control
Sponsors
Khoram-Abad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age range between 18-65 years Full consciousness (awareness of place, time, person) Ability to understand and speak Persian, Lori and Laki dialects Informed consent and willingness to participate in the study Having an anxiety score greater than 7 based on the DASS-21 questionnaire Mean arterial pressure greater than 70 mmHg and heart rate greater than 65 beats per minute
Exclusion criteria
Exclusion criteria: History of sudden hemodynamic changes Use of complementary medicine in the past week History of allergies, eczema, sensitivity to flower and plant odors, respiratory problems (asthma) History of migraine History of mental disorders and use of neuroleptic drugs Opioid addiction Connecting the patient to the ventilator Diabetes, flu, Alzheimer's disease, brain tumors, Huntington's disease, multiple sclerosis or MS, Parkinson's disease, radiation therapy that causes olfactory disorders. History of cardiopulmonary resuscitation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anxiety score on the DASS-21 questionnaire. Timepoint: Before the start of the intervention, after the end of the intervention on the first, second, third day. Method of measurement: DASS-21 Anxiety Questionnaire.;Mean arterial pressure. Timepoint: Before the intervention, 5 and 20 minutes, and 4 hours after the aromatherapy session in two sessions. Method of measurement: Cardiac monitoring device.;Heart rate. Timepoint: Before the intervention, 5 and 20 minutes, and 4 hours after the aromatherapy session in two sessions. Method of measurement: Cardiac monitoring device.;Respiratory rate. Timepoint: Before the intervention, 5 and 20 minutes, and 4 hours after the aromatherapy session in two sessions. Method of measurement: Cardiac monitoring device.;Arterial blood oxygen saturation. Timepoint: Before the intervention, 5 and 20 minutes, and 4 hours after the aromatherapy session in two sessions. Method of measurement: Cardiac monitoring device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShirin Narimani
Khoram-Abad University of Medical Sciences
Outcome results
None listed